SAN FRANCISCO, Jan. 6, 2021 /PRNewswire/ -- Nektar
Therapeutics' (Nasdaq: NKTR) President and Chief Executive Officer,
Howard Robin, is scheduled to
present at the upcoming 39th Annual J.P. Morgan Virtual Healthcare
Conference on Monday, January 11,
2021 at 11:50 a.m. Pacific
Time. The presentation and Q&A session will be
accessible via a Webcast through a link posted on the Investor
Events Calendar section of the Nektar website:
https://ir.nektar.com/events-and-presentations/events. This webcast
will be available for replay until February
10, 2021.
About Nektar
Nektar Therapeutics is a biopharmaceutical company with a
robust, wholly owned R&D pipeline of investigational medicines
in oncology, immunology, and virology as well as a portfolio of
approved partnered medicines. Nektar is headquartered in
San Francisco, California, with
additional operations in Huntsville,
Alabama and Hyderabad,
India. Further information about the company and its drug
development programs and capabilities may be found online at
http://www.nektar.com.
Contact:
For Investors:
Vivian
Wu of Nektar Therapeutics
628-895-0661
For Media:
Dan Budwick
of 1AB
973-271-6085
dan@1abmedia.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/nektar-therapeutics-president-and-ceo-howard-robin-to-present-at-the-39th-annual-jp-morgan-virtual-healthcare-conference-301202334.html
SOURCE Nektar Therapeutics